San Francisco, CA, USA, October 18, 2017– Trianni, Inc. (“TRIANNI”). today announced that Juno Therapeutics (NASDAQ: JUNO) has entered into […]
×
Recent Posts
- Trianni, Inc. and San Diego Biomedical Research Institute Announce License Agreement for the Trianni Mouse®
- Trianni, Inc. Announces Issuance of Patent in Japan
- Trianni, Inc. and MacroGenics, Inc. Announce License Agreement
- Trianni, Inc. and Simon Fraser University Announce Licensing Agreement for The Trianni Mouse™
- Gilead Enters Licensing Agreement With Trianni for Use of Trianni Transgenic Human Monoclonal Antibody Discovery Platform
Recent Comments